Tubulointerstitial disease mediators of injury: The role of endothelin

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 6, 2000, Pages 50-52

  Benigni, A ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY HYPERTROPHY; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE DAMAGE; KNOCKOUT MOUSE; MOUSE; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; PROTEINURIA; RAT; RENOVASCULAR HYPERTENSION;

EID: 0033646813     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.suppl_6.50     Document Type: Article

References (31)

1. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease
2. Understanding the nature of renal disease progression
3. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins
4. The endothelin B (ETB) receptor mediates compensatory renal hypertrophy
5. Increased renal endothelin production in rats with reduced renal mass
6. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression
7. Time course and localization of endothelin-1 gene expression in a model of renal disease progression
8. Passive Heymann nephritis: Evidence that angiotensin converting enzyme inhibition reduces proteinuria and retards renal structural injury
9. Angiotensin II blockade limits tubular protein overreabsorption and the consequent up-regulation of endothelin-1 gene in experimental membranous nephropathy
10. Renal expression of mRNAs for endothelin-1, endothelin-3 and endothelin receptors in NZB/W F1 mice
11. Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside-induced nephrosis
12. Gene expression for endothelins and their receptors in glomeruli of diabetic rats
13. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension
14. Regulation of the endothelin system in transgenic rats expressing the human endothelin-2 gene
15. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression
16. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation
17. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney
18. Effect of a specific endothelin A receptor antagonist on murine lupus nephritis
19. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli
20. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes
21. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy
22. Urinary excretion of endothelin-1 in normal subjects and patients with renal disease
23. Endothelin release from mesenteric arteries of spontaneously hypertensive rats
24. Endothelin: New discoveries and rapid progress in the clinic
25. Gene expression of the endothelin system in renal biopsies of proteinuric patients: Effect of angiotensin converting enzyme inhibition
26. Increased endothelin excretion in rats with renal failure induced by partial nephrectomy
27. Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat
28. An orally active ET(A)/ET(B) receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis
29. Changes in urinary excretion of endothelin-1-like immunoreactivity before and after unilateral nephrectomy in humans
30. Increased urinary endothelin-1 like immunoreactivity excretion in NIDDM patients with albuminuria
31. In situ expression of the endothelin gene family in human glomerulonephritis